Drug Type Small molecule drug |
Synonyms Parogrelil, INDI-702, NM-702 + [1] |
Target |
Mechanism PDE3 inhibitors(Phosphodiesterase 3 inhibitors), calcium channel inhibitors(Calcium Channel inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H19BrCl2N4O2 |
InChIKeyQWGUGDYWUADMGB-UHFFFAOYSA-N |
CAS Registry139145-84-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Intermittent Claudication | Phase 3 | - | - | |
Intermittent Claudication | Phase 3 | - | - | |
Peripheral Vascular Diseases | Phase 2 | US | 01 Apr 2003 | |
Asthma | Phase 2 | JP | - |